Visceral adiposity index outperforms common anthropometric indices in predicting 10‐year diabetes risk: Results from the ATTICA study

Visceral adiposity index (VAI) is a novel marker of visceral adipose tissue accumulation and dysfunction. The study aim was to explore the association of VAI with the 10‐year type 2 diabetes mellitus (T2DM) incidence in apparently healthy individuals and compare its T2DM predictive ability against common anthropometric indices.

[1]  S. Kahn,et al.  Design and validation of a novel estimator of visceral adipose tissue area and comparison to existing adiposity surrogates. , 2018, Journal of diabetes and its complications.

[2]  X. Pi-Sunyer.  Changes in body composition and metabolic disease risk , 2018, European Journal of Clinical Nutrition.

[3]  M. He,et al.  Using different anthropometric indices to assess prediction ability of type 2 diabetes in elderly population: a 5 year prospective study , 2018, BMC Geriatrics.

[4]  D. Panagiotakos,et al.  Single and combined effects of inflammatory markers on 10 year diabetes incidence: The mediating role of adiposity—Results from the ATTICA cohort study , 2018, Diabetes/metabolism research and reviews.

[5]  C. Fall,et al.  Comparison of regional fat measurements by dual-energy X-ray absorptiometry and conventional anthropometry and their association with markers of diabetes and cardiovascular disease risk , 2017, International Journal of Obesity.

[6]  A Novel Visceral Adiposity Index for Prediction of Type 2 Diabetes and Pre-diabetes in Chinese adults: A 5-year prospective study , 2017, Scientific Reports.

[7]  W. Teng,et al.  Comparison of anthropometric indices for predicting the risk of metabolic syndrome and its components in Chinese adults: a prospective, longitudinal study , 2017, BMJ Open.

[8]  D. Panagiotakos,et al.  Inflammation: a New Player in the Link Between Mediterranean Diet and Diabetes Mellitus: a Review , 2017, Current Nutrition Reports.

[9]  Guowei Huang,et al.  4-Year Trajectory of Visceral Adiposity Index in the Development of Type 2 Diabetes: A Prospective Cohort Study , 2016, Annals of Nutrition and Metabolism.

[10]  M. Janghorbani,et al.  The Visceral Adiposity Index in Comparison with Easily Measurable Anthropometric Markers Did Not Improve Prediction of Diabetes. , 2016, Canadian journal of diabetes.

[11]  P. Scherer,et al.  Targeting adipose tissue in the treatment of obesity-associated diabetes , 2016, Nature Reviews Drug Discovery.

[12]  P. Liu,et al.  Visceral Adiposity Index Is Associated with Pre-Diabetes and Type 2 Diabetes Mellitus in Chinese Adults Aged 20-50 , 2016, Annals of Nutrition and Metabolism.

[13]  T. Lauritzen,et al.  Associations between Ultrasound Measures of Abdominal Fat Distribution and Indices of Glucose Metabolism in a Population at High Risk of Type 2 Diabetes: The ADDITION-PRO Study , 2015, PloS one.

[14]  D. Panagiotakos,et al.  Ten-year (2002-2012) cardiovascular disease incidence and all-cause mortality, in urban Greek population: the ATTICA Study. , 2015, International journal of cardiology.

[15]  C. Giordano,et al.  Visceral adiposity index and DHEAS are useful markers of diabetes risk in women with polycystic ovary syndrome. , 2014, European journal of endocrinology.

[16]  S. Wang,et al.  Predictive value of visceral adiposity index for type 2 diabetes mellitus , 2015, Herz.

[17]  Jie Yang,et al.  The application of visceral adiposity index in identifying type 2 diabetes risks based on a prospective cohort in China , 2014, Lipids in Health and Disease.

[18]  Ioannis Kyrou,et al.  Clinical Problems Caused by Obesity , 2014 .

[19]  M. Fonseca-Alaniz,et al.  Adipose Tissue Inflammation and Insulin Resistance , 2012 .

[20]  W. Bao,et al.  Inflammatory Markers and Risk of Type 2 Diabetes , 2012, Diabetes Care.

[21]  F. Azizi,et al.  Predictive performance of the visceral adiposity index for a visceral adiposity-related risk: Type 2 Diabetes , 2011, Lipids in Health and Disease.

[22]  Massimo Midiri,et al.  Visceral Adiposity Index , 2010, Diabetes Care.

[23]  Angelos Evangelou,et al.  Reliability measures of the short International Physical Activity Questionnaire (IPAQ) in Greek young adults. , 2009, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[24]  N. Woods,et al.  Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study. , 2009, The Journal of clinical endocrinology and metabolism.

[25]  M. Stumvoll,et al.  Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. , 2007, The Journal of clinical endocrinology and metabolism.

[26]  D. Rader.  Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. , 2007, The American journal of medicine.

[27]  Christodoulos Stefanadis,et al.  Dietary patterns: a Mediterranean diet score and its relation to clinical and biological markers of cardiovascular disease risk. , 2006, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[28]  A. Goldfine,et al.  Inflammation and insulin resistance. , 2006, The Journal of clinical investigation.

[29]  C. Rattarasarn.  Physiological and pathophysiological regulation of regional adipose tissue in the development of insulin resistance and type 2 diabetes , 2006, Acta physiologica.

[30]  J. Després,et al.  Intra-abdominal obesity: an untreated risk factor for Type 2 diabetes and cardiovascular disease. , 2006, Journal of endocrinological investigation.

[31]  M. Lombardi,et al.  Visceral Fat in Hypertension: Influence on Insulin Resistance and β-Cell Function , 2004, Hypertension.

[32]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[33]  D. Panagiotakos,et al.  Epidemiology of cardiovascular risk factors in Greece: aims, design and baseline characteristics of the ATTICA study , 2003, BMC public health.

[34]  Y. Matsuzawa,et al.  [Visceral fat]. , 2002, Nihon rinsho. Japanese journal of clinical medicine.

[35]  M. J. Toth,et al.  Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women. , 2001, Diabetes care.

[36]  E. Boyko,et al.  Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. , 2000, Diabetes care.

[37]  A Trichopoulou,et al.  Reproducibility and relative validity of an extensive semi-quantitative food frequency questionnaire using dietary records and biochemical markers among Greek schoolteachers. , 1997, International journal of epidemiology.

[38]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[39]  J. Cornfield,et al.  A method of estimating comparative rates from clinical data; applications to cancer of the lung, breast, and cervix. , 1951, Journal of the National Cancer Institute.